Transaction underscores investor demand for value-add medical assets in high-growth healthcare corridors
WASHINGTON, D.C., January 2, 2026 – Cushman & Wakefield (NYSE: CWK) a leading global real estate services firm, announced today it brokered the $8.6 million sale of Talbot Medical, a 38,132-square-foot outpatient medical building in Silver Spring, Md., just outside Washington, D.C. The firm also arranged $5.3 million in acquisition financing for the buyer.
Cushman & Wakefield’s Healthcare Capital Markets team—Travis Ives, Gino Lollio, and Tyler Morss—along with Kevin Sidney from the firm’s Washington, D.C. office represented the seller, ESJ Capital Partners, and directly sourced the buyer, Miami-based Creative Equities LLC, led by Kevin Lurie.
Talbot Medical, located at 12120 Plum Orchard Drive, is home to five healthcare-focused tenants and anchored by Fresenius Kidney Care, which occupies nearly 20 percent of the building. Originally constructed in 1989 as a single-story office/flex property, the building has been repositioned into a modern outpatient medical facility.
“As healthcare providers grapple with rising costs and static or shrinking reimbursements, it’s more important than ever to find cost-effective solutions to mitigate real estate expenses,” said Ives, Cushman & Wakefield Executive Director. “Talbot Medical is a prime example of how repositioning an existing asset can deliver quality space in a convenient location at a fraction of the cost of new construction. This approach improves outcomes for occupiers and creates attractive investment opportunities for groups like ESJ Capital and Creative Equities. We’re seeing significant interest in similar value-add medical opportunities across the U.S.”
The property’s location, near Adventist HealthCare White Oak Medical Center—a 220-bed hospital—and the planned Viva White Oak development, a $2.8 billion, 280-acre mixed-use life sciences district approved for 12 million square feet of development, positions the asset for long-term growth and value creation.
“Financing value-add medical deals requires a deep understanding of both healthcare operations and capital markets,” added Morss, Director at Cushman & Wakefield, who arranged financing for Creative Equities. “Lenders are increasingly drawn to these assets because they combine stable tenancy with clear upside potential. Our experience in structuring debt for medical properties allowed us to secure competitive terms for the buyer, ensuring they can execute their business plan and unlock the property’s full value.”